3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Pain, Postoperative
9
Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Lung Neoplasms
8
Stomach Neoplasms
6
Colonic Neoplasms
6
Brain Neoplasms
6
Thyroid Neoplasms
5
Prostatic Neoplasms
5
Colorectal Neoplasms
5
Agnosia
4
Thromboembolism
3
Pain
3
Ovarian Neoplasms
3
Myofibroma
3
Head and Neck Neoplasms
3
Depression
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Uterine Neoplasms
2
Urinary Bladder Neoplasms
2
Supratentorial Neoplasms
2
Neoplasm Metastasis
2
Leiomyoma
2
Hemangioma
2
Arthritis, Rheumatoid
2
Vomiting
1
Visceral Pain
1
Uterine Cervical Neoplasms
1
Interventions
Saline Solution
1
Infliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Depressive Disorder, Treatment-Resistant
×
Saline Solution
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts